CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2005-10-07): Hepatitis does not lower quality of life in HIV patients

Epidemiology

Hepatitis does not lower quality of life in HIV patients

Last Updated: 2005-10-07 13:30:25 -0400 (Reuters Health)

NEW YORK (Reuters Health) - There appears to be no significant difference in the quality of life among patients with HIV infection alone and those who also have viral hepatitis, according to researchers.

Dr. Brennan M. R. Spiegel told Reuters Health, "despite the widely held belief that coinfection with HIV and viral hepatitis is much worse on quality of life than infection with HIV alone, we found that there is no real difference in quality of life between patients with one versus both infections."

"This is important," he added, "because some patients with both HIV and viral hepatitis -- such as hepatitis B or C -- are told that their quality of life will improve dramatically if they receive treatment for the viral hepatitis."

Dr. Spiegel of the UCLA/VA Center for Outcomes Research and Education, Los Angeles and colleagues examined data on a nationally representative sample of 1874 HIV patients.

Of these, 279 had hepatitis C coinfection and 122 had hepatitis B coinfection. Twenty of the patients had both hepatitis B and C coinfection, according to the report in the September issue of the American Journal of Gastroenterology.

By means of responses to interviews conducted at baseline and twice during follow-up, the researchers established that there were no initial differences in physical and mental health or in quality of life across groups. At follow-up there were still no differences in disease burden as assessed by quality-of-life questionnaires.

"Our data suggest that treating viral hepatitis in the setting of HIV might not improve quality of life, independent of whether or not it improves other biological outcomes like liver damage," continued Dr. Spiegel.

This does not imply that "treatment of viral hepatitis is contraindicated in the setting of HIV," he added. But "should simply be kept in mind for patients who are unsure about whether or not to receive additional antiviral therapy for hepatitis, or for those who are otherwise ineligible for treatment."

Am J Gastroenterol 2005;100:1984-1994.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.